Nogo - Antibody Trial (NISCI Study)

Nogo – Antibody Trial (NISCI Study) – Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury. The Investigator’s Meeting for the NISCI Study will be held in Prague, Czech November 29-30, 2017

Clinical License

Name*
Institute, Clinic or Hospital Profession*
Address*
Street Address Address Line 2 City State / Province / Region ZIP / Postal Code Country
Email*
Do you agree to the CLINICAL LICENSE AGREEMENT?*
- I agree to the terms of the CLINICAL LICENSE AGREEMENT
- I do not agree to the terms of the CLINICAL LICENSE AGREEMNET
CLINICAL LICENSE AGREEMENT: PLEASE READ THE FOLLOWING UP TO DATE LICENSE AGREEMENT ("AGREEMENT") CAREFULLY BEFORE CONTINUING. WITH YOUR ACCEPTANCE, THIS IS A LEGAL CONTRACT BETWEEN NEURAL OUTCOMES CONSULTING, INC. ("NOCI")/UNIVERSITY HEALTH NETWORK (UHN) AND YOU ("YOU"). BY CLICKING ON THE "ACCEPT" BUTTON, OR BY DOWNLOADING, ACCESSING OR USING THE CONTENT, YOU ACCEPT ALL OF THE TERMS AND CONDITIONS OF THIS AGREEMENT AND AGREE TO BE BOUND BY THIS AGREEMENT. IF YOU DO NOT ACCEPT THE TERMS OF THIS AGREEMENT, YOU ARE NOT PERMITTED TO USE THE CONTENT. IN SUCH CASE, CLICK THE "I do not agree to the terms of the CLINICAL LICENSE" BUTTON. The license granted in this AGREEMENT is only for the personal use of individual healthcare providers or consumers. License agreements for all other professionals and organizations must be arranged through UHN. Please contact Dr.Kalsi-Ryan skr@neuraloutcomes.com for further inquiries about licensing.